Suchergebnisse - "Back, David J"

PubPharm (13)

1

Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy : A Three-Arm Pharmacokinetic Evaluation Over 48 Weeks

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2016

von Scarsi, K. | Darin, K. | Nakalema, S. | +8

2

Effect of intermittent rifampicin on the pharmacokinetics and safety of raltegravir

enthalten in: The Journal of antimicrobial chemotherapy | 2015

von Reynolds, H. | Chrdle, A. | Egan, D. | +5

3

Population pharmacokinetic modeling of the association between 63396C->T pregnane X receptor polymorphism and unboosted atazanavir clearance

enthalten in: Antimicrobial agents and chemotherapy | 2010

von Schipani, A. | Siccardi, M. | D'Avolio, A. | +17

4

Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individuals

enthalten in: The Journal of antimicrobial chemotherapy | 2008

von Dickinson, L. | Boffito, M. | Back, D. | +7

5

Pharmacokinetic analysis to assess forgiveness of boosted saquinavir regimens for missed or late dosing

enthalten in: The Journal of antimicrobial chemotherapy | 2008

von Dickinson, L. | Boffito, M. | Khoo, S. | +4

6

Lopinavir/ritonavir pharmacokinetics in HIV/HCV-coinfected patients with or without cirrhosis

enthalten in: Therapeutic drug monitoring | 2008

von Micheli, V. | Regazzi, M. | Dickinson, L. | +11

7

Intracellular and plasma pharmacokinetics of nevirapine in human immunodeficiency virus-infected individuals

enthalten in: Clinical pharmacology and therapeutics | 2005

von Almond, L. | Edirisinghe, D. | Dalton, M. | +3

8

Lopinavir/ritonavir combined with twice-daily 400 mg indinavir : pharmacokinetics and pharmacodynamics in blood, CSF and semen

enthalten in: The Journal of antimicrobial chemotherapy | 2004

von Isaac, A. | Taylor, S. | Cane, P. | +6

9

Effect of mycophenolate mofetil on the pharmacokinetics of antiretroviral drugs and on intracellular nucleoside triphosphate pools

enthalten in: Clinical pharmacokinetics | 2004

von Sankatsing, S. | Hoggard, P. | Huitema, A. | +7

ErratumIn: Clin Pharmacokinet. 2005;44(12):1246

10

Lopinavir protein binding in vivo through the 12-hour dosing interval

enthalten in: Therapeutic drug monitoring | 2004

von Boffito, M. | Hoggard, P. | Lindup, W. | +5